Search

everythinglearnresearchcommunity

for

Search:↓

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Oleanolic acid improved hair growth in mice by affecting hair growth pathways and reducing inflammation.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Hair loss in children is often caused by scalp infections, immune disorders, hair pulling, stress, and requires careful treatment due to emotional effects.

The treatment using phenol and dexamethasone was effective for alopecia areata with no recurrence in 6 months.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Ruxolitinib can cause a delayed skin reaction on the nose.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.